Variability of the preC/C region of hepatitis B virus genotype A from a South African cohort predominantly infected with HIV
- PMID: 23925707
- PMCID: PMC4559853
- DOI: 10.1002/jmv.23695
Variability of the preC/C region of hepatitis B virus genotype A from a South African cohort predominantly infected with HIV
Abstract
Hepatitis B virus (HBV) is a serious global health problem, and HBV genotype is an important determinant of disease progression and treatment outcome. The aim of this study was to assess variations of the precore/core (preC/C) region in HBV genotype A. Sequencing of the preC/C and surface (S) genes of HBV was performed on plasma samples from 20 HBV/HIV co-infected and 5 HBV mono-infected individuals. All preC/C study sequences clustered with subgenotype A1, except for two which clustered with subgenotype D4 reference strains. The nucleotide and amino acid variability was far higher in the preC/C region than in the S region. Mutations associated with reduction or failure of HBV e-antigen (HBeAg) production were observed, with a preC start codon mutation being common (24%). Other mutations (e.g., P5H/L and I97L) associated with severe liver disease were also noticed, some of which were located in the major histocompatibility restricted sites. PreC/C intergenotype nucleotide divergence was >7%, while subgenotypes differed by 2.5-7%. Several study sequences were highly divergent from other African subgenotype A1 strains. This study showed that HBeAg-negative chronic hepatitis B is underestimated in subgenotype A1, and also highlighted the variant South African A1 strains. The major advantage of preC/C sequencing is that it informs patient management as HBeAg-negative chronic hepatitis B responds poorly to conventional interferon-α therapy, and some guidelines treat HBeAg-negative chronic hepatitis B differently from HBeAg-positive chronic hepatitis B. These data suggest that subgenotype A1 may be more involved in severe HBV-related diseases.
Keywords: HBeAg-negative chronic hepatitis B; amino acids; genotyping; mutations; nucleotides.
© 2013 Wiley Periodicals, Inc.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures




References
-
- Alavian SM, Carman WF, Jazayeri SM. HBsAg variants: Diagnostic-escape and diagnostic dilemma. J Clin Virol. 2013;57:201–208. - PubMed
-
- Araujo NM, Waizbort R, Kay A. Hepatitis B virus infection from an evolutionary point of view: How viral, host, and environmental factors shape genotypes and subgenotypes. Infect Genet Evol. 2011;11:1199–1207. - PubMed
-
- Buti M, Rodriguez-Frias F, Jardi R, Esteban R. Hepatitis B virus genome variability and disease progression: the impact of pre-core mutants and HBV genotypes. J Clin Virol. 2005;34:S79–S82. - PubMed
-
- Faure E. Alternative peptide-fusion proteins generated by out-of-frame mutations, just upstream ORFs or elongations in mutants of Human Hepatitis B Viruses. Virus Res. 2006;117:185–201. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical